Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

Instead, make sure you get compounded semaglutide products from reputable companies that are committed to safety and transparency. To give you an idea of the standards to look out for, Hers offers ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Semaglutide is a drug used for weight loss. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you may need to take them ...

Stanford Medicine scientists have discovered a naturally occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s in animals — without the dreaded side effects. “ ...

Previous studies have found that taking semaglutide after weight loss surgery may be effective to help lose more weight or ...

The FDA said compounders have until April or May, depending on their regulatory status, to stop compounding, distributing or dispensing semaglutide injection products. All semaglutide doses are ...

The company has already filed more than 100 lawsuits related to “copycat” semaglutide products, most under claims of false advertising or deceptive and unfair trade practices. “No one should ...